Talis Biomedical Corp
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and li… Read more
Market Cap & Net Worth: Talis Biomedical Corp (TLIS)
Talis Biomedical Corp (PINK:TLIS) has a market capitalization of $2.83 Million ($2.83 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #34187 globally and #11140 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Talis Biomedical Corp's stock price $1.56 by its total outstanding shares 1822820 (1.82 Million).
Talis Biomedical Corp Market Cap History: 2021 to 2025
Talis Biomedical Corp's market capitalization history from 2021 to 2025. Data shows change from $109.64 Million to $2.83 Million (-74.07% CAGR).
Talis Biomedical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Talis Biomedical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
32.96x
Talis Biomedical Corp's market cap is 32.96 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $109.64 Million | $8.19 | -$190.46 Million | 13387377.66x | N/A |
| 2022 | $12.19 Million | $3.65 Million | -$110.89 Million | 3.34x | N/A |
| 2023 | $13.58 Million | $412.00K | -$62.01 Million | 32.96x | N/A |
Competitor Companies of TLIS by Market Capitalization
Companies near Talis Biomedical Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Talis Biomedical Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Talis Biomedical Corp Historical Marketcap From 2021 to 2025
Between 2021 and today, Talis Biomedical Corp's market cap moved from $109.64 Million to $ 2.83 Million, with a yearly change of -74.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.83 Million | -11.14% |
| 2024 | $3.19 Million | -76.51% |
| 2023 | $13.58 Million | +11.44% |
| 2022 | $12.19 Million | -88.89% |
| 2021 | $109.64 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Talis Biomedical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.83 Million USD |
| MoneyControl | $2.83 Million USD |
| MarketWatch | $2.83 Million USD |
| marketcap.company | $2.83 Million USD |
| Reuters | $2.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.